Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of Immunotherapy
-
Published:2023-12
Issue:
Volume:
Page:
-
ISSN:2405-4569
-
Container-title:European Urology Focus
-
language:en
-
Short-container-title:European Urology Focus
Author:
Hassler Melanie R.,
Moedlagl Verena,
Hindinger Hanna,
Krauter Johanna,
Klager Sonja,
Resch Irene,
Huebner Nicolai,
Yurdakul Ozan,
Ofner Heidemarie,
Korn Stephan M.,
D'Andrea David,
Gust Kilian,
Shariat Shahrokh F.ORCID
Reference28 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001
3. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration;Margulis;Cancer,2009
4. Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy;Fosså;Br J Cancer,1996
5. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005